Crinetics Pharmaceuticals
CRNX
CRNX
111 hedge funds and large institutions have $885M invested in Crinetics Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 46 increasing their positions, 31 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 116 → 111 (-5)
11% less capital invested
Capital invested by funds: $995M → $885M (-$110M)
12% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 17
Holders
111
Holding in Top 10
5
Calls
$2.57M
Puts
$5K
Top Buyers
| 1 | +$21M | |
| 2 | +$14.8M | |
| 3 | +$12.6M | |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$12.3M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$10.1M |
Top Sellers
| 1 | -$9.11M | |
| 2 | -$9.01M | |
| 3 | -$6.53M | |
| 4 |
ACM
Altium Capital Management
New York
|
-$4.48M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$1.87M |